Penpulimab
1. 系统已在2025-07-30 10:36:09对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/32816421
其他信息:
PMID: 32816421
作者:
摘要: No information is available on the clinical use of penpulimab during breastfeeding. Because penpulimab is a large protein molecule with a molecular weight of 150,000 Da, the amount in milk is likely to be very low.[1] It is also likely to be partially destroyed in the infant's gastrointestinal tract and absorption by the infant is probably minimal.[2] The manufacturer recommends that breastfeeding be discontinued during therapy and for 4 months after the last dose.
